Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 506 of 6351
-
Could a daily probiotic prevent iron deficiency in pregnancy?
Prevention Recruiting nowMaternal iron deficiency (ID) and iron deficiency anemia (IDA) is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate. Therefore, preventing maternal IDA in at-risk women is critical. …
Phase 2 • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Can plasma help heal the brain after injury?
Disease control Recruiting nowThe goal of this clinical trial is to learn about treatment with fresh frozen plasma (FFP) in individuals with moderate to severe traumatic brain injury. The two main question\[s\]it aims to answer are: * Is the FFP treatment safe? * Does the FFP treatment impact the 24-hour, 3-…
Phase 2/3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New stent could silence debilitating ringing in the ears
Symptom relief Recruiting nowThis study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity…
Sponsor: Sonorous NV, Inc • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Could a daily aspirin save lives after pneumonia in the elderly?
Disease control Not yet recruitingAcute pneumonia is a very common disease, and one of the leading causes of hospitalization and death in France. Almost a century after the discovery of penicillin, no major breakthrough has significantly reduced pneumonia-related mortality. While the choice of an appropriate anti…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC
-
New hope for tough colon cancer: combo therapy targets BRAF mutation
Disease control Not yet recruitingThis is an open-label, single-arm, single-center phase II clinical study, aiming to investigate the safety and efficacy of Aipalolitovorelizumab (QL1706) combined with bevacizumab plus standard chemotherapy regimen as first-line treatment for patients with MSS/pMMR metastatic col…
Phase 2 • Sponsor: Yanqiao Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Kenya project aims to eradicate cervical cancer with HPV vaccine and better screening
Prevention Not yet recruitingThis project serves to continue a community-based initiative, known as the Kenya Mother-Daughter Cervical Cancer Eradication Project, or the Mother-Daughter Project (MDP), in the Webuye region of Western Kenya. The MDP project, since its initiation in 2018, has sought to develop …
Sponsor: Indiana University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Asthma drug could shield hearts after attack, new trial hopes
Disease control Recruiting nowAcute myocardial infarction (AMI) is one of the leading causes of patient mortality worldwide. Each year, over 8 million people globally die from AMI, with approximately 30% of these cases being ST-segment elevation myocardial infarction (STEMI). Despite the continuous developmen…
Phase 3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
AI-ECG could catch deadly lung condition before It's too late
Diagnosis Recruiting nowThis study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation throug…
Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Experimental cell therapy targets lung scarring in End-Stage disease
Disease control Not yet recruitingIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal interstitial lung disease characterized by irreversible scarring, leading to respiratory failure. With limited treatment options and a poor prognosis, new therapies are urgently needed. This study investigates a…
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Heart valve trial: fix both leaks at once or just one?
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of combined mitral and tricuspid transcatheter edge-to-edge repair (TEER) versus isolated mitral TEER in the treatment of patients with mitral regurgitation (MR) combined with tricuspid regurgitation (TR). The expected object…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat brain autoimmune diseases
Disease control Not yet recruitingThis is an investigator-initiated, single-center, open-label study of C-CAR168, an autologous bi-specific CAR-T therapy targeting CD20 and BCMA, for the treatment of adult patients with central nervous system autoimmune diseases refractory to standard therapy
Phase 1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Triple therapy offers hope for hard-to-treat liver cancer
Disease control Not yet recruitingThis is a prospective, open-label, single-arm phase II study designed to evaluate the efficacy and safety of FOLFOX-based hepatic arterial infusion chemotherapy (HAIC) in combination with donafenib and pucotenlimab as first-line treatment in patients with unresectable intrahepati…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the efficacy and safety of spatially fractionated radiotherapy combined with the PraG strategy in the treatment of soft tissue sarcoma (STS). The main questions it aims to answer are: 1. Can spatially fractionated radio…
Phase 2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common antioxidant save newborns from deadly sepsis?
Disease control Not yet recruitingNeonatal sepsis (NS) is a life-threatening condition characterized by systemic inflammation in response to infection during the first 28 days of life. Nowadays, it is generally acknowledged that one of the critical pathogenic mechanisms involved in neonatal sepsis is oxidative st…
Phase 3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo aims to tackle tough rectal cancer
Disease control Not yet recruitingResearch objective: To compare the efficacy and safety of Capox + Bev versus Capox + Bev combined with primary site radiotherapy + (Iparomlimab and Tuvonralimab) as the first-line treatment for RAS Mutation/pMMR metastatic rectal cancer patients. Study endpoint: Primary endpoin…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Virus turns body into cancer-fighting factory for stubborn lymphoma
Disease control Recruiting nowTo study the safety and effectiveness of oncolytic Vaccinia VIrus-Delivered Targeted CD19 In Vivo CAR-T/M Therapy for Refractory/Relapsed B-Cell Lymphoma
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis phase II study evaluates the efficacy and safety of neoadjuvant chemoimmunotherapy consisting of camrelizumab (PD-1 inhibitor), paclitaxel, and carboplatin in patients with resectable locally advanced (Stage III-IVA) squamous cell carcinoma of the oral cavity and/or larynx. …
Phase 2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo aims to keep High-Risk leukemia in remission before transplant
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of a venetoclax-based consolidation therapy versus conventional consolidation chemotherapy in newly diagnosed adult patients with high-risk acute myeloid leukemia (AML) who have achieved complete remission (CR)…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New test could prevent unnecessary surgery for common skin precancers
Diagnosis OngoingActinic keratoses are precancerous skin lesions that are the most common among all cancers and precancerous conditions in fair-skinned populations. The distinctive feature of these actinic keratoses is that some progress into skin cancers known as cutaneous carcinomas, while othe…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Aging in place: could mobile teams keep nursing home residents out of the hospital?
Disease control Recruiting nowThis multicenter, cluster-randomized, unblinded quality-improvement study evaluates whether home-based clinical assessment by municipal acute care teams can safely reduce hospital admissions among nursing home residents experiencing acute illness or clinical deterioration during …
Sponsor: Copenhagen University Hospital at Herlev • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC